Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for B-Raf (gene)
Most Relevant Literature
- Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
- Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.
- Computational analysis of natural product B-Raf inhibitors.
- Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor.
- Differences in BRAF V600E mutation between the epithelium and mesenchyme in classic ameloblastoma.
Most Relevant Clinical Trials
- Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease
- Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF M…
- Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot S…
- Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preop…
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorect…
